JCDecaux renews Heathrow advertising contract for 8 yearsParis, 30 June 2026 – JCDecaux SE (Euronext Paris:DEC, the number one outdoor advertising company worldwide, announces today the renewal of its contract with Heathrow, the most connected airport in the world, with a record 84.5 million passen…
Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 studyParis, June 30, 2026. Positive results from the Baby-COMET phase 3, single-arm, open-label study (clinical study identifier: NCT04910776), demonstrated that Nexviazyme (avalglucosidase alfa) me…
VALLOUREC AWARDED MAJOR CONTRACT BY AZULE ENERGY FOR THE GREATER PAJ OFFSHORE DEVELOPMENT IN ANGOLAMeudon, on June 30, 2026 – Vallourec, a world leader in premium seamless tubular solutions, announces that it has been awarded a major contract by Azule Energy, the joint venture formed by Eni and BP…
By Kelly CloonanDBV Technologies is working to incorporate feedback from the Food and Drug Administration before seeking marketing approval for a patch to treat peanut allergies.The biopharmaceutical company said Monday it has had continuing discussions with the FDA in recent weeks to prepare to su…
ABIVAX/ Key word(s): Study results/StudyAbivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database29.06.2026 / 22:05 CET/CESTThe issuer is solely responsible…
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety DatabasePARIS, France – June 29, 2026 – 10:05 pm CEST – Abivax SA (Euronext Paris:FR00123332…
Châtillon, France, June 29, 2026DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for FilingDBV Technologies Euronext:DBV – ISIN:FR0010417345 – Nasdaq Stock Mar…
Communication from Worldline’s Board of DirectorsParis, La Défense, [29 / 06 / 2026] – The Board of Directors of Worldline acknowledged the resignation of Mr. Daniel Schmucki, director of the Company initially appointed upon proposal of SIX Group AG in 2020, effective immediately, following his ann…
In accordance with the regulations relating to share buybacks, Technip Energies PARIS:TE declares the following purchases of its own shares from June 22, 2026, to June 26, 2026.These transactions were carried out as part of the buyback program with a discretionary mandate carried out by an investme…
Press releaseParis, June 29 2026HOPSCOTCH evolves its governance structureand establishes an expanded Executive Committee to drive its global ambitionHOPSCOTCH, the international communications group founded in France, is today transforming its Management Committee into an Executive Committee (COME…
Disclosure of transactions in own sharesParis, France (June 29, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026, EssilorLuxottica declares that from June 24, 2026, to June 25, 2026, inclusive, the following share buybacks were car…
Share buyback programAggregated disclosure of transactions in own sharescarried out from June 22 to June 26, 2026Paris, June 29, 2026,Pursuant to the authorization granted by the Combined Shareholders’ Meeting held on April 29, 2026, to operate on its shares and in accordance with the regulations r…
DISCLOSURE OF TRADING IN OWN SHARESFROM 06/22/2026 TO 06/26/2026Meudon (France), on June 29th, 2026Share buyback program (ISIN Code:FR0013506730 implemented in accordance with the authorization given by the Shareholders' General Meeting of Vallourec SA LEI:969500P2Q1B47H4MCJ34 on May 21, 2026 (twel…
Press Release74Software:Disclosure of transactions in own sharesParis, June 29, 2026 – In accordance with the authorization given by the Combined General Meeting of May 19, 2026, for the implementation of a share buyback program, 74Software LEI:96950022O6SP7FQONJ77 declares below the purchases of i…
REGULATED INFORMATIONDisclosure of trading in own sharesDisclosure of trading in own shares on 22, 23, 24, 25 and 26 June 2026.As part of the authorisation granted by the Annual General Meeting of 23 April 2026I. Summary presentationII. Detailed presentationhttps://www.bouygues.com/app/uploads/2026…
Significant advances were presented in individualized neoantigen vaccines, with TG4050 progressing in head and neck cancer and TG4070 launching in non-small cell lung cancer. Manufacturing is transitioning to a scalable cell line process, and the SNIPER platform is validated for future indications…
TG4050 and TG4070 advance as individualized neoantigen vaccines, with TG4070 entering phase I for lung cancer and leveraging the in-house SNIPER platform. Manufacturing shifts to scalable cell lines, supporting faster, automated production and expansion into new indications, including Monkeypox and…
By Edith HancockEuropean aerospace leader Airbus will get a 3 billion euros ($3.42 billion) loan from the European Investment Bank as European Union officials seek to build out the bloc's own technological capabilities to fend off mounting competition from the U.S. and China.The EIB said that an in…
Individualized neoantigen vaccine programs TG4050 and TG4070 are advancing in early-stage HNSCC and NSCLC, with TG4050 showing 100% 2-year DFS in Phase 1 and Phase 2 efficacy data expected by Q1 2028. Scalable cell line manufacturing and AI-driven neoantigen selection support expansion, while the c…
BRUSSELS (dpa-AFX) - France's equity benchmark CAC 40 drifted lower on Monday as uncertainty over the fragile ceasefire between the U.S. and Iran, concerns about interest rates amid higher oil prices rendered the mood cautious. Investors are also focusing on the Sintra Forum, an annual ECB event th…